The human Descemet's membrane and lens capsule: Protein composition and biomechanical properties.


Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
12 2020
Historique:
received: 13 06 2020
revised: 18 10 2020
accepted: 20 10 2020
pubmed: 5 11 2020
medline: 2 3 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

The Descemet's membrane (DM) and the lens capsule (LC) are two ocular basement membranes (BMs) that are essential in maintaining stability and structure of the cornea and lens. In this study, we investigated the proteomes and biomechanical properties of these two materials to uncover common and unique properties. We also screened for possible protein changes during diabetes. LC-MS/MS was used to determine the proteomes of both BMs. Biomechanical measurements were conducted by atomic force microscopy (AFM) in force spectroscopy mode, and complemented with immunofluorescence microscopy. Proteome analysis showed that all six existing collagen IV chains represent 70% of all LC-protein, and are thus the dominant components of the LC. The DM on the other hand is predominantly composed of a single protein, TGF-induced protein, which accounted for around 50% of all DM-protein. Four collagen IV-family members in DM accounted for only 10% of the DM protein. Unlike the retinal vascular BMs, the LC and DM do not undergo significant changes in their protein compositions during diabetes. Nanomechanical measurements showed that the endothelial/epithelial sides of both BMs are stiffer than their respective stromal/anterior-chamber sides, and both endothelial and stromal sides of the DM were stiffer than the epithelial and anterior-chamber sides of the LC. Long-term diabetes did not change the stiffness of the DM and LC. In summary, our analyses show that the protein composition and biomechanical properties of the DM and LC are different, i.e., the LC is softer than DM despite a significantly higher concentration of collagen IV family members. This finding is unexpected, as collagen IV members are presumed to be responsible for BM stiffness. Diabetes had no significant effect on the protein composition and the biomechanical properties of both the DM and LC.

Identifiants

pubmed: 33147472
pii: S0014-4835(20)30584-4
doi: 10.1016/j.exer.2020.108326
pii:
doi:

Substances chimiques

Eye Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108326

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Willi Halfter (W)

Department of Ophthalmology, University of Basel, Switzerland. Electronic address: whalfter@pitt.edu.

Suzette Moes (S)

Proteomics Core Facility, Biozentrum, University of Basel, Switzerland. Electronic address: suzette.moes@gmail.com.

Kathrin Halfter (K)

Munich Cancer Registry, Institute of Medical Informatics, Biometry and Epidemiology, Maximilian University Munich, Germany. Electronic address: Halfter@ibe.med.uni-muenchen.de.

Monica S Schoenenberger (MS)

Swiss Nanoscience Institute, Nano Imaging Lab, University Basel, Switzerland. Electronic address: monica.schoenenberger@unibas.ch.

Christophe A Monnier (CA)

Department of Ophthalmology, University of Basel, Switzerland. Electronic address: christophe.a.monnier@gmail.com.

Joanna Kalita (J)

Biozentrum and the Swiss Nanoscience Institute, University of Basel, Switzerland.

Daphne Asgeirsson (D)

Biozentrum and the Swiss Nanoscience Institute, University of Basel, Switzerland. Electronic address: daphne.asgeirsson@gmail.com.

Tatjana Binggeli (T)

Department of Ophthalmology, University of Basel, Switzerland. Electronic address: t.binggeli@gmail.ch.

Paul Jenoe (P)

Proteomics Core Facility, Biozentrum, University of Basel, Switzerland. Electronic address: p.jenoe@bluewin.ch.

Hendrik P N Scholl (HPN)

Department of Ophthalmology, University of Basel, Switzerland; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Switzerland; Wilmer Eye Institute, Johns Hopkins University, Baltimore, MA, USA. Electronic address: hendrik.scholl@usb.ch.

Paul Bernhard Henrich (PB)

Department of Ophthalmology, University of Basel, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: bernardohenrich@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH